US · USD
RYTM
Rhythm Pharmaceuticals Inc
- Day's range
- $89.36 – $91.37
- Day's volume
- $31.7M
- 52-week range
- $75.82 – $117.62
Follow RYTM in the Fuolio
See how RYTM weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountRYTM in numbers
- Market cap
- $6.2B
- P/E
- -679.99
- P/B
- 59.45
- Dividend yield (12m)
- 0.00%
RYTM price history
RYTM risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | -18.49% | +165.99% | +893.52% |
| Volatility (annualized) | 36.20% | 47.59% | 115.25% |
| Largest drawdown | -25.42% | -28.48% | -70.14% |
| Positive months | 3/12 | 14/36 | 29/60 |
How much did investing in RYTM return?
$1,000.00 invested on 11/01/2021 would be worth $9,935.20 today.
- Value today in RYTM
- $9,935.20
- Return over the period
- +893.52%
- Return per year
- +59.31%
- In the S&P 500
- $1,707.51
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
RYTM fundamentals
Valuation
- P/E-679.99
- P/B59.45
- EV/EBITDA—
- EV/EBIT-29.55
- EV/Revenue24.71
- P/EBIT-30.67
- P/S25.64
- P/OCF-58.40
- P/FCF—
- Earnings yield-3.38%
- PEG ratio—
- Earnings per share-$0.13
- Book value per share$1.50
Debt
- Net debt-$224.8M
- Net debt/EBITDA—
- Net debt/Equity-2.18
- Debt/Equity1.03
- Current ratio3.45
- Quick ratio3.20
- Cash ratio2.68
Efficiency
- Gross margin89.00%
- EBITDA margin—
- Operating margin-83.62%
- Net margin-3.75%
- Asset turnover0.55
Profitability
- ROE-8.74%
- ROA-2.06%
- ROIC—
- Payout—
RYTM's indicators by year
Multiples at each year's closing price; margins and returns from that year's statements.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| P/E | -37,189.72 | -13,581.11 | -14,970.16 | -9,123.78 | -7,215.57 | -11.13 | -7.19 | -12.49 |
| P/B | 52.56 | 162.88 | 16.29 | 6.25 | 1.77 | 8.96 | 3.60 | 3.76 |
| Earnings per share | -$0.00 | -$0.00 | -$0.00 | -$0.00 | -$0.00 | -$2.67 | -$3.19 | -$2.15 |
| Book value per share | $2.04 | $0.34 | $2.82 | $4.66 | $5.65 | $3.32 | $6.38 | $7.15 |
| ROE | -0.14% | -1.20% | -0.11% | -0.07% | -0.02% | -80.46% | -50.08% | -30.08% |
| ROIC | — | — | -329,208.93% | -67.80% | -59.85% | -54.13% | -34.29% | -21.02% |
| Gross margin | 89.73% | 89.73% | 87.99% | 90.98% | 81.01% | — | — | — |
| EBITDA margin | -100.93% | -203.50% | -236.94% | -754.13% | -5,365.98% | — | — | — |
| Net margin | -0.10% | -0.20% | -0.24% | -0.77% | -2.21% | — | — | — |
RYTM's financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | $189.8M | $130.1M | $77.4M | $23.6M | $3.2M | $0 |
| Cost of revenue | -$19.5M | -$13.4M | -$9.3M | -$2.1M | -$599K | — |
| Gross profit | $170.3M | $116.8M | $68.1M | $21.5M | $2.6M | — |
| EBITDA | -$191.5M | -$264.8M | -$183.5M | -$178.3M | -$169.2M | -$135.9M |
| EBIT | -$192M | -$265.5M | -$184.4M | -$179.2M | -$170.1M | -$136.6M |
| Financial result | -$4M | $5.2M | $243K | -$2M | $100.4M | $2.6M |
| Income before tax | -$196M | -$260.3M | -$184.1M | -$181.1M | -$69.6M | — |
| Income tax | -$497K | -$346K | -$564K | — | — | — |
| Net income | -$196.5K | -$260.6K | -$184.7K | -$181.1K | -$69.6K | -$134M |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
Does RYTM pay dividends?
RYTM has no distributions on record.
About Rhythm Pharmaceuticals
- Sector
- Manufacturing
Questions about RYTM
How much is RYTM today?
RYTM is at $88.92 (-2.04% on the day), last traded on 10/07/2026.
What are the P/E and P/B of RYTM?
RYTM trades at a P/E of -679.99 and a P/B of 59.45.
How much did RYTM return in 12 months?
RYTM returned -18.49% in 12 months, with annualized volatility of 36.20% and a largest drawdown of -25.42%.